NCT02034253View on ClinicalTrials.gov

Glutamate, Brain Connectivity and Duration of Untreated Psychosis

CompletedOBSERVATIONAL
Enrollment

134

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

November 30, 2018

Study Completion Date

November 30, 2018

Conditions
SchizophreniaPsychosisSchizoaffective Disorder
Interventions
DRUG

Risperidone

Patients with psychosis will be provided a 16 week regimen of the antipsychotic drug Risperidone in accordance with standard care.

Trial Locations (1)

35294

Sparks Center, Birmingham

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER

NCT02034253 - Glutamate, Brain Connectivity and Duration of Untreated Psychosis | Biotech Hunter | Biotech Hunter